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Abstract
Microarrays were developed to profile the level of proteins associated with calcium regulation in sarcoplasmic reticulum (SR) isolated from
porcine Longissimus muscle. The microarrays consisted of SR preparations printed onto to glass slides and probed with monoclonal antibodies to
7 target proteins. Proteins investigated included: ryanodine receptor, (RyR), dihydropyridine receptor, (DHPR), triadin (TRI), calsequestrin (CSQ),
90 kDa junctional protein (JSR90), and fast-twitch and slow-twitch SR calcium ATPases (SERCA1 and SERCA2). Signal from a fluorescently-
labeled detection antibody was measured and quantitated using a slide reader. The microarray developed was also employed to profile Longis-
simus muscle SR proteins from halothane genotyped animals. Significant (P<0.05) reductions in levels of several proteins were found including:
RyR, CSQ, TRI, DHPR and SERCA2 in SR samples from halothane positive animals. The results illustrate the potential of microarrays as a tool
for profiling SR proteins and aiding investigations of calcium regulation.
© 2006 Elsevier B.V. All rights reserved.
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Protein microarray represents a new proteomic technology
that is rapidly gaining interest because of its ability to facilitate a
variety of investigations including protein profiling and
protein–protein interaction [1–4]. Protein and DNA micro-
arrays are similar in that they require small amounts of sample.
Typically, 1–10 ng of target molecules (protein or peptide) are
printed in an array onto glass slides containing nitrocellulose
pads or an activated surface. Printed proteins can then be probed
with labeled antibodies or ligands. Microarrays require low
reagent volumes (μL) and have short processing times. These
attributes conserve expensive and/or limited reagents and
facilitate high sample throughput applications. Additionally,
several arrays can be printed onto a single slide offering the
capability of multiplexed analyses.
Detection of the desired component is accomplished by
using fluorescently labeled probes. High sensitivity detection is
achieved in protein microarrays through the use of laser-
induced excitation employed by most slide readers. Several
studies have affirmed the sensitivity of microarrays. A
comparison of conventional and microarray based ELISA,
found the microarray to be 4-fold more sensitive for the
detection of autoimmune antibodies [5]. Greater detection
sensitivity is possible in microarrays using signal amplification
methods such as tyramide signal amplification (TSA), rolling
circle amplification (RCA), or quantum dots (Qdots) [6–8].
Protein microarrays show promise as a tool to characterize
the compliment of proteins in cells and tissues. A cell's
proteome is constantly being modified by extrinsic and intrinsic
factors. Growth, environmental change, and pathogenesis are
but a few examples of the many influences resulting in changes
to protein expression and protein post-translational modifica-
tion. A variety of analyses are possible for proteome
characterization using protein microarray approaches including:
ELISA-based assay, protein–protein interaction investigation,
and enzymatic activity assay [1–3]. However, one of the more
interesting innovations for microarray analysis is reverse phase
microarray (RPMA). RPMA analysis involves immobilizing of
complex protein samples onto the slide (typically nitrocellulose
pads) followed by probing with fluorescently labeled antibody.
Samples are usually prepared as total extracts or cell lysates
with denaturing methods similar to those used for 2-
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dimensional electrophoresis. Recent refinements in the sensi-
tivity of signal detection (TSA, Qdots) have enabled measure-
ment of low abundance proteins in heterogenous samples.
RPMAs are being used to unravel the complexities signaling
pathways that result in a cascade of events [3,4]. RPMAs have
been used for profiling phosphorylated proteins associated with
ovarian [9,10] and prostrate [11,12] cancers. It is hoped that the
analysis capability provided by RPMAs will contribute
significantly to the ability to diagnose and treat diseases.
The capabilities of microarray analysis also show promise
for addressing other areas of research as well. Investigation of
calcium regulation in muscle is one example where microarray
analysis will potentially be of benefit. The SR is a membrane
organelle that functions in the regulation of intracellular calcium
concentration [13,14]. Abnormal calcium regulation has been
linked to diseases such as malignant hyperthermia, myocardial
failure, and muscular dystrophy. A mutation (R615→C) in
RyR protein is thought to be a primary cause of malignant
hyperthermia [15]. This mutation is often referred to as the
halothane (Hal) gene because it is possible for individuals with
this defect to experience malignant hyperthermia triggered by
administration of the anesthetic, halothane. Since this signifi-
cant discovery, numerous other mutations in RyR have been
reported [16]. Additionally, altered levels of calcium regulatory
proteins in the SR occur in response to pathophysiological
conditions. Studies employing immunoblotting found lower
levels of RyR and DHPR proteins in malignant hyperthermia
susceptible porcine Longissimus muscle [17], reduced level of
calcium pump in failing myocardium [18,19] and reduced level
RyR isoform expression in smooth muscle of dystrophic mice
[20]. These studies and others have demonstrated the need for
methods to accurately profile SR proteins.
The goal of this work was to develop protein microarrays for
the purpose of profiling the level of SR proteins important to
calcium regulation. Proteins selected for examination in this
study include: RyR, DHPR, CSQ, TRI, and junctional
sarcoplasmic reticulum protein (JSR 90). In addition, calcium
ATPase enzymes (SERCA1 and SERCA2) were also selected
for screening. Specifically, a reverse phase type of microarray
was developed for profiling these proteins in SR preparations.
Data from these arrays were then assessed for potential
relationship between the microarray determined SR protein
profile and halothane genotyped animals.
Materials used in these experiments included: Precast
polyacrylamide gels, polyvinylidene flouride (PVDF) mem-
brane, blotting and electrophoresis materials were obtained
from Bio-Rad (Hercules, CA). Monoclonal antibodies for the
following proteins were purchased from Affinity BioReagents
(Golden, CO): MA3-921, anti-dihydropyridine receptor alpha-2
subunit from rabbit skeletal muscle; MA3-933, junctional
sarcoplasmic reticulum protein (90 kDa) from rabbit skeletal
muscle; MA3-913, calsequestrin from rabbit skeletal muscle,
and MA3-912 SERCA1 ATPase from rabbit skeletal muscle;
MA3-919, SERCA2 ATPase from canine cardiac muscle; and
MA3-927, triadin from rabbit fast twitch skeletal muscle.
Additionally, anti-ryanodine monoclonal antibody MAB3086
made from C-terminal peptide of the receptor protein was
purchased from Chemicon International (Temecula, CA).
Secondary antibody (A90-116A Goat anti-mouse IgG) was
obtained from Bethyl labs (Montgomery, TX). Alexaflour 546
monoclonal antibody labeling kits and Sypro Ruby dye were
obtained from Molecular Probes (Eugene, OR). Reagents for
the BCA assay were obtained from Pierce (Rockford, IL). All
water used for the preparation of reagents in this study was
purified to 18 mΩ using reverse osmosis.
The Longissimus muscle samples used in these experiments
came from a set of 24 porcine animals that were previously
halothane genotyped. These samples were a generous gift of Dr.
Dave Gerrard at Purdue University (West Lafayette, IN).
Individual samples were classified as halothane positive
(Hal+), halothane negative (Hal−) or halothane carrier (Halc).
The animals were genotyped using the method of O'Brien et al.
[21]. All samples came from a population of adult animals.
Longissimus muscle samples were taken immediately at
death, frozen in liquid nitrogen, and stored at −80 °C until
used for SR isolation.
Sarcoplasmic reticulum membranes were isolated from
porcine skeletal muscle using a variation of the method
described by Saito et al, [22]. All steps of the procedure were
performed at 1–2 °C unless stated otherwise. Briefly, the SR
membrane fraction was isolated from frozen muscle by
homogenizing 5 g of minced muscle for 90 s in a Warring
blender in 25 mL of 300 mM sucrose in 5 mM imidazole pH 7.2
containing 100 μm E-64c and 1 mM PMSF. After homogeniza-
tion, the solution was adjusted to 10 mM EGTA by addition of
an appropriate volume of 250 mM EGTA, pH 7.2, and
centrifuged at 9000×g for 15 min. The resulting supernatant
was filtered through a nylon mesh strainer and centrifuged at
35,000 g for 90 min at 4 °C. The pellet containing the SR
fraction was taken up in a minimal volume of 5 mM imidazole,
100 μM E-64c and 1 mM PMSF and centrifuged on a 1.0 mL
cushion of 30% sucrose, 5 mM imidazole, 100 μM E-64c and
1 mM PMSF at 130,000×g for 1 h The pellet from this spin was
quick frozen in liquid nitrogen and stored at −80 °C.
SDS-PAGE was used to visualize the profile SR proteins in
sample preparations and to screen the specificity of antibodies
used in microarray analysis. Prior to electrophoresis, protein
level in SR preparations was determined from an aliquot of
sample solubilized in 0.2% SDS using the BCA (bicinchoninic
acid) method (Pierce, Rockford, IL). Electrophoresis was
performed on 4–15% polyacrylamide gels at 200 V constant
voltage for 65 min or until the dye front migrated out of the gel.
Proteins were visualized by staining with 0.1% Coomassie
Brilliant Blue containing 10% acetic acid, 50% methanol and
destained using 5% acetic acid, 10% methanol.
Immunblotting was performed on SDS-PAGE separated
sample using a 4–15% gradient gel, containing a long single
well of approximately 11 cm in width. Following electro-
phoretic separation, the gel width was trimmed to 8 cm and
incubated in cathode Tris/CAPS transfer buffer (60 mM Tris,
40 mM CAPS pH 9.4, 0.1% SDS). The separation was then
transferred electrophoretically to PVDF membrane. Anode
transfer buffer contained 60 mM Tris, 40 mM CAPS pH 9.4,
and 15% methanol. Transfer electrophoresis was performed in
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a semi-dry apparatus at 1.3 mAmps per cm2 for 60 min. The
PVDF membrane was removed from the transfer unit and
blocked overnight in 5% Casein, 0.1% BSA dissolved Tris
Buffered saline containing 0.1% Tween 20 (TBS-T). The
membrane was then placed in an incubation manifold
containing 16 channels. Each channel spanned the original
separation from top to bottom and was approximately 0.5 cm
in width. Channels were used for antibody incubation and had
an internal volume of 200 μL. The manifold facilitated
probing of a single membrane with all 7 antibodies used in
this study. Two hundred μL of primary antibodies (diluted
1:100 with TBS-T for RyR, DHPR, CSQ, Tri and JSR90)
were incubated per channel with the membrane. Antibodies
for SERCA 1 and 2 were diluted 1:500 in TBS-T. Incubation
with primary antibodies was performed for 2 h at 20 °C. The
membrane was removed from the manifold, washed several
times and incubated for 1 h with Goat-anti-mouse IgG HRP
conjugate (1:5000 dilution in TBS-T). Bound antibody was
detected using a chemiluminescence system (SuperSignal
West Dura, Pierce Rockford IL) and recorded on Kodak
BioMax film.
Samples were prepared for microarray analysis by mixing
an aliquot of the 0.2% SDS-solubilized SR fraction with an
equal volume of printing buffer (0.3 M NaHPO4 pH 8.5, 30%
glycerol, 0.2% trehalose and 0.01% Tween-20). Printing was
performed using a Gene Machine Omnigrid 100 printer
(GeneMachine, San Carlos, CA) using an ArrayIt (Santa
Clara, CA) Stealth (SMP8xB) microspotting pin with a spot
volume of 5 nL onto NHS (N-hydroxysuccinimide ester)
functionalized slides (OptArrat, Denver, CO). SR proteins
were printed at a final concentration of 0.5 ng/nL. Each spot
contained 2.5 ng of protein and spots were spaced approxi-
mately 350 μm apart. Arrays containing all 24 samples were
printed. Each sample was printed 5 times for a total of 120
spots. Two replicate arrays (240 total spots) were printed per
antibody probe. Printed arrays were incubated overnight at
20 °C at 60% humidity. The next day, unreacted sites on the
slide were blocked by immersion in 50 mM ethanolamine,
50 mM borate, pH 8.0. Slides were then rinsed with RO water,
dried with a stream of nitrogen and stored at −20 °C.
The aim of this microarray analysis was to measure
differences in the composition of target proteins of the SR
fraction. Thus, it was also necessary to assess the total amount
of protein printed per spot. This was accomplished by staining
duplicate arrays with a protein-detecting fluorescent dye
(SYPRO Ruby). Briefly, 200 μL of SYPRO Ruby was added
to the slide and incubated for 5 min at 20 °C. The slide was
rinsed gently with RO H2O and air-dried. The fluorescence
intensity of protein spots was read at 543 nm excitation and
614 nm emission in a ScanArray 5000 reader (Perkin Elmer).
This procedure enabled assessment of consistency of protein
printing.
Incubations with antibodies were performed using silicone
isolating masks (Grace BioLabs) that fit over the arrays.
Adhesive backing on the mask kept solutions from mixing on
the slide. Each slide typically contained two sets of arrays with
corresponding incubation wells. Wells formed by the isolating
mask had an internal volume of 250 μL. Individual arrays were
incubated for 2 h with 200 μL of the appropriate monoclonal
antibody, diluted 1:100 in PBST. Following incubation, arrays
were washed 3 times with PBST. Detection of bound
monoclonal antibody was performed with goat anti-mouse
polyclonal antibody conjugated to Alexa Fluor 546 (Molecular
Probes). Briefly, labeling of detection antibodies was performed
by mixing the dye (succinimidyl ester form) with 100 μg of
purified goat anti-mouse IgG antibody (Bethyl Labs). Labeled
antibody was separated from free dye using a small (1 mL) size
exclusion column. The efficiency of labeling was determined
from the absorbance ratio (280 to 558 nm). Using the extinction
coefficient for the dye, a ratio of 2–3 dye per protein molecules
was routinely obtained.
Detection of bound IgG in the array was performed by
adding 200 μL of fluorescently labeled antibody (diluted
1:1,000 with PBS-T) for each set of arrays. Arrays were then
incubated for 1 h at 20 °C. At the end of the incubation, arrays
were rinsed 5 times with PBS-T. The adhesive backed mask was
then carefully removed and the slide surface rinsed gently with
RO H2O. Slides were dried with a stream of nitrogen and
analyzed using laser excitation at 543 nm with emission
measured at 570 nm in a ScanArray 5000 instrument. The
ScanArray instrument generates TIFF and Bitmap images for
quantification and visual evaluation, respectively. Images were
analyzed using ImaGene (BioDiscovery Inc., El Segundo, CA)
version 5.0. Imagene software was used to define and quantify
the spot area and intensity. Spots that were abnormal in size or
shape were omitted from the analysis. Signal intensity from all
valid spots was averaged and the standard error of the means
calculated. Averaged signal intensities were also normalized for
the amount of protein spotted. Normalized values were obtained
by dividing averaged sample signal intensity by the averaged
protein signal determined from corresponding SYPRO-stained
arrays. The resulting data (expressed as normalized sample
signal intensity) from 2 replicate arrays were averaged and used
to examine differences between samples. A total of 24 animals
representing halothane positive (4), negative (10) and hetero-
zygote (10) (carrier) genotypes were investigated in this study.
These data were analyzed using the One-way ANOVA function
of SAS and significant differences were determined using
Fishers Least Significant Difference [23].
Isolation of the SR-containing fraction from porcine skeletal
muscle by differential sedimentation centrifugation was per-
formed essentially as described by Saito et al, [22]. However,
the isolation procedure used in here was halted after obtaining
130,000 g (microsomal) pellets. It was possible to routinely
obtain 1–2 mg of SR preparation for microarray analysis from
5 g muscle samples.
The profile of SR proteins obtained by SDS-PAGE is shown
in lane a of Fig. 1A. This lane contains a separation of a halothane
negative sample on a 4–15% gradient gel. Protein bands in this
separation range in size from 630 kDa to about 10 kDa. The
highest Mr bands represent a minor portion of the sample and
have an approximate Mr of 630 kDa and 385 kDa (a doublet).
Bands with Mr ranging from 175 kDa to 10 kDa represent a
majority of proteins found in this fraction. Specifically, SR
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proteins found in bands ranging from 65 to 23 kDa represent the
dominant components. The protein profile observed in Fig. 1A
(lane a) was similar to that reported by others for porcine skeletal
muscle SR preparations [17,24]. SDS-PAGE separations of SR
fractions presented by these authors showed fewer bands,
especially in the 30–60 kDa range. This difference may be
due to the additional sample fractionation (sucrose density
gradients) that was employed prior electrophoretic separation
[17,24].
The specificity of antibodies used in this study was
confirmed by immunoblotting the same halothane negative
SR protein sample (Fig. 1A. lanes b through h). Anti-RyR
monoclonal antibody (MAB3086) was observed to label a
single band at about 630 kDa (Fig. 1A, lane b), but not the
385 kDa doublet observed in the protein separation (lane a). The
385 kDa doublet may represent RyR degradation products that
were not recognized by the antibody and also not measured in
the subsequent microarray analysis. Monoclonal antibody
MA3-921 against DHPR alpha 2 subunit labeled a single
band with Mr of approximately 165 kDa (lane c). The Mr is
higher than the expected value of 143 kDa [25,26]. However,
the size reported here may have resulted from the gradient gel
system which compresses the mid range separation in favor of
higherMr resolution. Lanes d and e show that antibodies against
SERCA 1 (MA3-912) and SERCA2 (MA3 919) recognize
single bands in their respective lanes. The relative intensity of
the bands in lanes d and e reflect the differences in the level of
these ATPases in Longissimus muscle. SERCA1 ATPase level
is greater than SERCA2 ATPase in fast twitch muscle [27].
Lane f shows that monoclonal antibody (MA3-913) against
CSQ resulted in a major immunoreactive band withMr of about
65 kDa. Some additional staining products can be seen in the
regions above the major band. However, these products
represent a small amount of lateral antibody leakage that
occurred during incubation of the PVDF membrane in the
manifold. Lane g shows a major immunoreactive band resulting
from incubation with monoclonal antibody (MA3-927) against
TRI. The major band corresponds to a Mr of 95 kDa. A much
less intense immunoreactive band, likely representing a
degradation product of TRI, can be seen just below the
95 kDa band. Finally, lane h shows a single reactive product
with monoclonal antibody (MA3-933) against Junctional SR
(90 kDa) protein. Additional immunoblotting was performed on
SR preparations from a single representative halothane negative
(a) and positive (b) sample using antibodies against RyR,
DHPR, CSQ and TRI (Fig. 1B). Noticeably reduced immunor-
eactive bands were observed in the halothane positive SR
sample for DHPR, CSQ, and TRI proteins. Only slight a
difference was observed in the amount of immunoreactive
product for RyR between halothane positive and negative
sample.
The microarray approach used in this work was similar to the
RPMA mode demonstrated others [3,4]. However, our SR
protein preparations were printed at a constant level onto a glass
surface. The substrate used in these arrays contained an
activated (NHS) surface by which sample proteins were
covalently attached. In contrast, nitrocellulose used for most
RPMA applications retains proteins by electrostatic charge.
Both methods have been shown to work well in capturing
proteins. Nitrocellulose slides can provide greater protein
binding capacity, but may also contribute to decreased signal
to noise ratios due to non-specific binding of detection antibody.
Numerous conditions were investigated to optimize printing of
SR proteins on glass microarrays. Inclusion of the detergent
SDS was necessary to solubilize SR proteins. However SDS
greatly reduced the surface tension of the solution resulting in
unwanted spreading of the spot. The problem was compensated
for by the addition of glycerol to the print buffer. In addition to
improving viscosity, glycerol served as a humectant and helped
to inhibit desiccation of the printed proteins. SYPRO staining of
arrays was essential to these microarray analyses in that it
enabled correction for small differences in the amount of SR
protein printed.
All primary antibodies used in this study were monoclonal.
The dilution of each primary antibody was examined
individually. It was found that 200 μL of a 1:100 dilution
provided substantial excess antibody relative to the amount of
protein printed in an array and was therefore used for all
arrays. Fluorescently labeled goat anti-mouse IgG antibody
was used to detect monoclonal antibodies bound to protein in
the spot. In dilution experiments, 200 μL of a 1:1000 dilution
was found to be the greatest dilution of labeled antibody that
would provide sufficient detection of the bound protein-
specific monoclonals in printed arrays. Fluorescence signal
from the detection antibody was laser-induced and the signal
to noise ratio was 2.0 or greater for all antibody arrays. Non-
specific binding of detection antibody was tested by adding
Fig. 1. SDS-PAGE and immunoblotting of SR preparation. (A) Forty μg of SR
fraction from a halothane negative Longissimus muscle sample was separated on
4–15% SDS-PAGE gel (lane a). Mr values are indicated to the left of this lane.
Lanes b–h contain immunoblots of the same sample probed with antibodies to:
RyR (b), DHPR (c), SERCA1 (d), SERCA2 (e), CSQ (f), TRI (g), and JSR90
(h). (B) Identical loads of SR fraction from halothane negative (a) and positive
(b) samples were separated on 4–15% SDS-PAGE gel and probed by
immunoblotting with antibodies to: RyR, DHPR, CSQ, and TRI.
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the same dilution to arrays in which primary antibody was
absent.
An image of the resulting microarray is shown in Fig. 2. This
figure contains a composite array image together with
corresponding control (incubations without primary antibody).
The control indicates a very low level of non-specific binding
by the detection antibody. Each sub-array consists of 5
halothane negative SR samples printed 5 times per sample,
for a total of 25 spots. Spot signal intensity (low to high) is
represented in the array image by a change in color from light
blue to orange-red. Overall, the relative intensities of these
arrays show that SERCA1 and JSR 90 have the highest and
lowest signal intensities, respectively. Signals from the other
target proteins (RyR, DHPR, CSQ, SERCA2 and TRI) fall
within this range of intensities. Quantitative assessment of
microarrays was achieved using the Imagene software followed
by statistical analyses.
Analytical arrays were constructed containing all 24
samples, printed as 5 replicate spots per sample (a total of
120 spots per array). Variation between replicate arrays was
determined by calculating the RSD values from the adjusted
signal intensities of 5 replicate spots printed per sample. RSD
values were then averaged by genotype (halothane positive,
negative or carrier) and the results shown in Fig. 3. RSD
values for individual target proteins ranged from 9% to 30%
within both replicate slides. The highest level of RSD variation
within slides occurred for proteins present in the lowest
amount (JSR90). Overall there was good agreement between
the slides. It is of interest to note that lowest level of RSD
variation between slides was observed for the halothane
positive genotype samples. It was found that all 7 target
protein RSD values were in good agreement between slides for
this genotype.
Data from the microarray analysis for each protein were
next examined for differences between animals representing
the three genotypes (halothane positive, negative and carrier)
(Table 1). Significant differences (P<0.05) were found in the
level of several SR proteins predominantly between halothane
positive and negative samples (Table 1). Specifically, a 43%
reduction in the level of RyR1 and a 37% reduction DHPR α2
subunit were found in SR from Hal positive samples. In
addition, significantly decreased levels of CSQ (44%),
SERCA2 (24%), and TRI (40%) were found in SR from
halothane positive samples. This result is in agreement with the
reduction in the level of DHPR, CSQ and TRI proteins for
halothane positive SR samples shown in our immunoblot
results (Fig. 1B). However, the slight difference observed in
the level of RyR immunoreactive band between halothane
positive and negative SR samples was in contrast to the
significantly lower level found for this protein by the
microarray analysis. This may have resulted from sample
variability. The immunoblot result was obtained from single
halothane positive and negative samples, whereas the micro-
array analysis compared 4 positive to 10 negative samples. SR
samples from heterozygous (halothane carrier) animals did not
show significant differences in the level of most proteins
investigated. The only significant difference was found for TRI
with the halothane positive sample (Table 1). TRI level was
approximately 35% lower in the halothane positive sample.
This may represent an interesting result since a reduction in
TRI might equate to lower calcium binding (storage) capacity
in malignant hyperthermia susceptible animals.
Results presented here regarding expression of major
calcium regulatory proteins are in agreement with other
investigations suggesting that decreased levels of key proteins
may be a factor in calcium regulation abnormalities. Significant
reductions in RyR (38%) and DHPR (55%) proteins were found
in the SR of Longissimus muscle of malignant hyperthermia
susceptible porcine animals using immunoblotting methods
[17]. Reduction in RyR protein was significant for both
Fig. 2. SR Protein Microarray. This figure represents a composite containing arrays for each of the 7 target SR proteins. Each array contains 5 halothane negative SR
samples printed in 5 replicate spots per row. Arrays were individually incubated with monoclonal antibodies (diluted 1:100) for: RyR, DHPR, CSQ, SERCA1,
SERCA2. TRI, and JSR90 proteins. Bound antibodies were detected with fluorescently labeled goat-anti-mouse IgG. The array labeled control contains printed
halothane negative SR proteins incubated solely with the detection antibody (fluorescently labeled goat-antimouse IgG) at the same level of dilution (1:1000) used for
detection of the monoclonals.
1433J.S. Schulz et al. / Biochimica et Biophysica Acta 1764 (2006) 1429–1435
homozygote and heterozyogte (carrier) RyR genotypes. Lower
levels of both RyR and DHRP protein was suggested as a cause
for altered calcium homeostasis in malignant hyperthermia
susceptible animals [17]. Additionally, a study conducted by
immunoblotting of SR proteins in human patients with failing
dilated cardiomyopathy found no change in proteins associated
with calcium binding and release (CSQ and RyR) compared to
non-failing controls [19]. However, this study did find a
significant decrease in the level of SR ATPase in failing hearts.
The authors suggested that elevated sarcoplasmic level in
failing heart tissue may have resulted from decreased calcium
pump function.
In contrast, expression of SR proteins associated with
calcium regulation was not altered in human muscle susceptible
to malignant hyperthermia [26]. This study used immunoblot-
ting of biopsy samples taken from vastus lateralis muscle. The
authors demonstrated little or no observable difference in the
immunoreactive bands for several SR proteins including: RyR,
DHPR (α1 s and α2), CSQ, Junctin, SERCA1, and SERCA2.
The report did demonstrate a halothane-induced oligomeriza-
tion of RyR and SERCA1 by electrophoretic gel shift assay in
SR preparations isolated from malignant hyperthermia suscep-
tible individuals. Explanations for the lack of difference in the
profile of SR proteins in this study compared to our results are
not readily apparent. However, Glover et al. [26] selected
samples for their study based on an in-vitro contracture test
rather than the genotyping approach used to select samples in
our work. Additionally, Glover et al. [26] drew their conclusions
from immunoblotting of a small number of representative
samples of normal and malignant hyperthermia susceptible
individuals. We experienced similar differences between
immunoblots of single RyR halothane positive/negative sam-
ples and microarray data (Fig. 1B/Table 1).
Abnormalities in calcium regulation are linked to adverse
health consequences. Mutations in the calcium channel protein
RyR likely represent a major portion of the causation of
malignant hyperthermia in humans and the analogous condition
in porcine animals. However, there is evidence that alterations
in the profile calcium regulatory proteins (DHPR), or binding
(CSQ and SERCA1 and 2) proteins may represent contributing
factors to the disease state. Cardiomyopathy and muscular
dystrophy are conditions that result in altered calcium
regulatory protein profile [19,20,28]. These studies and others
have demonstrated the need for methods to accurately profile
SR proteins.
The results presented here show that microarrays represent a
viable and advantageous technology to profile SR proteins. A
comprehensive SR profile may include probes for RyR, DHPR,
CSQ, TRI, JSR90, Junctin, SERCA1 and 2, Calsequstrin-like
proteins, Calreticulin and isoforms or subunits of many of the
above. Additionally, valuable information may be derived from
sarcoplasmic calcium modulating proteins such as calmodulin
and FKBP12. Microarray technology would enable quantitative
assessment of multiple targets. Combined protein microarray
and genomic data represent a promising way forward to
determine the underlying biology of calcium regulation
abnormalities and provide appropriate diagnostic tools. Future
Fig. 3. Replicate Microarray RSD. RSD values were calculated from normalized
signal intensities of the 5 spots printed per sample. RSD values for each target
protein (CSQ, RyR, JSR90, DHPR, SERCA1, SERCA2, and TRI) were then
averaged by genotype; halothane positive (+), negative (−) or carrier(c). RSD
values for the replicate arrays are shown as bar graphs in figures A and B.
Table 1
Microarray analysis summary of SR proteins in halothane genotyped animals
Protein Genotype
Hal− (n=10) Halc (n=10) Hal+ (n=4)
CSQ 4.00±0.37a 3.17±0.26a,b 2.24±0.42b
DHPR 4.85±0.44a 4.30±0.21a,b 3.05±0.29b
JSR90 1.63±0.15a 1.90± .033a 1.10±0.24a
RyR 4.76±0.48a 3.77±0.49a,b 2.70±0.43b
SERCA1 11.67±0.85a 11.03±0.89a 11.90±1.02a
SERCA2 2.93±0.17a 2.55±0.14a,b 2.23±0.24b
TRI 4.01±0.33a 3.74±0.26a 2.40±0.37b
SR preparations from Longissimus muscle of 24 animals genotyped as
halothane positive (+), negative (−) or carrier(c) were profiled by the
microarray procedure described using monoclonal antibodies specific for RyR,
DHPR, CQS, SERCA1, SERCA2, TRI, and JSR90. The number (n) of animals
in each group was: 4 positive, 10 negative, and 10 carrier. Values in the table
were obtained from an average of two arrays in which each sample was printed
5 times. Each value is represented as normalized signal intensity mean±SEM.
Superscripts (a, b, c) were used to denote statistical differences. Values with
differing superscripts denote significant difference (P<0.05) between means.
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development of microarray analysis for SR protein profiling
would benefit from the ability to detect these targets in printed
whole extracts. It is likely that nitrocellulose substrates in
combination with signal amplification methods would enable
accomplishment of this task.
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